Effects of Dietary Conditions on Drug Response
NCT04315961 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2024-08-09
Summary
This non-treatment study will examine how different dietary conditions may affect a person's response to commonly used drugs.
Conditions
- Healthy
Interventions
- DRUG
-
Blinded drug dose conditions
Capsules will contain commonly prescribed or over-the-counter drugs or placebo. Capsules in this study may contain sedatives, muscle relaxants, or anti-anxiety medications, stimulant drugs/weight loss medications, or antihistamines which must remain blinded for the purposes of this study.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - lead OTHER
Principal Investigators
-
Mary M Sweeney, PhD · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-18
- Primary Completion
- 2023-02-02
- Completion
- 2023-02-02
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214
NCT01458899 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy Adults
NCT04393597 ·Status: WITHDRAWN ·Phase: PHASE1
-
Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
NCT02154022 ·Status: ENROLLING_BY_INVITATION
-
A Study of TAK-227 in Healthy Adults
NCT05818956 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150
NCT01118559 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
NCT04183686 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects
NCT06608329 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet
NCT01125670 ·Status: COMPLETED ·Phase: PHASE1
-
The Food Effect on the Pharmacokinetics of NVP-1402
NCT03340480 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants
NCT06397508 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)
NCT01465412 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Induced Liver Injury (DILI) Network Retrospective
NCT00360646 ·Status: RECRUITING
-
Absorption, Metabolism, Excretion and Absolute Bioavailability
NCT03250039 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions
NCT04283019 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects
NCT02225626 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers
NCT02533102 ·Status: COMPLETED ·Phase: PHASE1
-
The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy Subjects
NCT04686825 ·Status: COMPLETED ·Phase: PHASE1
-
National CounterACT Initiative
NCT03597438 ·Status: COMPLETED
-
Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect Study
NCT02049528 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function
NCT01563562 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
NCT02126514 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930
NCT03034486 ·Status: COMPLETED ·Phase: PHASE1
-
RDEA3170 AME Study
NCT01910506 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants
NCT06887010 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
NCT03565861 ·Status: COMPLETED ·Phase: PHASE1